Chemoinformaics analysis of Homoflavoyadorinin-B
| Molecular Weight | 608.549 | nRot | 9 |
| Heavy Atom Molecular Weight | 576.293 | nRig | 29 |
| Exact Molecular Weight | 608.174 | nRing | 5 |
| Solubility: LogS | -3.59 | nHRing | 3 |
| Solubility: LogP | 0.449 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 75 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 43 | No. of Aromatic Carbocycles | 2 |
| nHetero | 15 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 28 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 15 | No. of Arom Bond | 17 |
| nHA | 15 | APOL | 80.1274 |
| nHD | 7 | BPOL | 45.1226 |
| QED | 0.152 |
| Synth | 4.638 |
| Natural Product Likeliness | 1.993 |
| NR-PPAR-gamma | 0.876 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.992 |
| HIA | 0.968 |
| CACO-2 | -6.274 |
| MDCK | 0.0000501 |
| BBB | 0.295 |
| PPB | 0.68849 |
| VDSS | 0.586 |
| FU | 0.212671 |
| CYP1A2-inh | 0.017 |
| CYP1A2-sub | 0.649 |
| CYP2c19-inh | 0.007 |
| CYP2c19-sub | 0.137 |
| CYP2c9-inh | 0.003 |
| CYP2c9-sub | 0.135 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.249 |
| CYP3a4-inh | 0.033 |
| CYP3a4-sub | 0.058 |
| CL | 2.098 |
| T12 | 0.339 |
| hERG | 0.055 |
| Ames | 0.52 |
| ROA | 0.03 |
| SkinSen | 0.028 |
| Carcinogencity | 0.105 |
| EI | 0.005 |
| Respiratory | 0.011 |
| NR-Aromatase | 0.908 |
| Antiviral | Yes |
| Prediction | 0.865193 |